Time to Invest in L...
Health Care: Drugs
Ampio Pharmaceuticals Inc. (AMPE: NASDAQ)
$5.06 -0.02 | -0.39%
05/24/13 - 12:24 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 17.68M | 11.36M | 671.28K | 527.00 |
| Receivables | 0.00 | 0.00 | 5.71K | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 164.89K | 43.12K | 60.53K | 0.00 |
| Total Current Assets | 17.85M | 11.41M | 737.52K | 527.00 |
| Property, Plant & Equipment, Gross | 84.70K | 84.70K | 0.00 | 0.00 |
| Accumulated Depreciation & Depletion | 25.42K | 8.48K | 0.00 | 0.00 |
| Property, Plant & Equipment, Net | 59.29K | 76.23K | 0.00 | 0.00 |
| Intangibles | 420.47K | 465.92K | 0.00 | 0.00 |
| Other Non-Current Assets | 7.52M | 7.54M | 0.00 | 30.15K |
| Total Non-Current Assets | 8.00M | 8.08M | 0.00 | 30.15K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 25.85M | 19.48M | 737.52K | 30.68K |
| Accounts Payable | 1.20M | 630.62K | 1.67M | 91.77K |
| Short Term Debt | 0.00 | 0.00 | 2.13M | 0.00 |
| Other Current Liabilities | 384.77K | 610.91K | 398.67K | 1.20K |
| Total Current Liabilities | 1.64M | 1.29M | 4.75M | 100.60K |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 381.25K | 431.25K | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 381.25K | 431.25K | 0.00 | 0.00 |
| Total Liabilities | 2.02M | 1.72M | 4.75M | 100.60K |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 23.83M | 17.76M | -4.01M | -69.92K |
| Common Par | 3.70K | 3.11K | 1.71K | 0.00 |
| Additional Paid In Capital | 63.69M | 46.06M | 5.96M | 28.63K |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -39.77M | -28.18M | -9.82M | -98.54K |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -90.64K | -127.52K | -153.46K | 0.00 |
| Total Capitalization | 23.83M | 17.76M | -4.01M | -69.92K |
| Total Equity | 23.83M | 17.76M | -4.01M | -69.92K |
| Total Liabilities & Stock Equity | 25.85M | 19.48M | 737.52K | 30.68K |
| Total Common Shares Outstanding | 37.01M | 31.08M | 17.11M | 929.72K |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 33.98M | 26.01M | 16.29M | 929.72K |
| Diluted Weighted Shares Outstanding | 33.98M | 26.01M | 16.29M | 929.72K |
| Number of Employees | 13 | 12 | 11 | 1 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AMPE
- Portfolio NameUser Type
- UserFlying Monkey King's Actuals
- ContributorStocks Under-$10 Setting Up...
- UserFirst Try
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
Latest AMPE Headlines from TheStreet
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Ampio's Eye Drug Trial Design Won't Pass FDA Muster 04.02.13 | 09:04 am
- 5 Stocks Under $10 Set to Soar 09.20.12 | 01:09 pm
- A Biotech Short Seller Responds To Critics 07.17.12 | 08:07 am
- Ampio Insiders, Aided by PR Blitz, Soon Free to Sell Millions of Shares 07.02.12 | 01:07 pm
- Biotech Stock Mailbag: Osiris, Arena, Ampio 06.22.12 | 06:06 am
- Ampio Spins A Tale of Curing Blindness 06.11.12 | 03:06 pm
- Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm 04.05.12 | 05:04 am
- 6 Stocks Under $10 Moving Higher 12.14.11 | 01:12 pm
Press Releases for AMPE
- Ampio Receives FDA Clearance To Initiate Clinical Trial Of Ampionâ¿¢ For The Treatment Of Osteoarthritis Of The Knee: Patient Treatments Have Begun. - PR Newswire 04.02.13 | 04:04 am
- Ampio Receives FDA Acceptance Of Its Patient Outcome For Premature Ejaculation (POPE) Questionnaire, Paving The Way For Its US Pivotal Trial On Zertaneâ¿¢ - PR Newswire 03.11.13 | 04:03 am
- Ampio Pharmaceuticals Initiates Clinical Trial Of Optinaâ¿¢ In Diabetic Macular Edema (DME): First Patient Dosed - PR Newswire 02.27.13 | 04:02 am
- Ampio Pharmaceuticals Modifies Ampionâ¿¢ IND For Osteoarthritis Of The Knee To Include A Dose Escalation Run-In Study And Prepares To Launch Pivotal Clinical Trial - PR Newswire 02.25.13 | 04:02 am
- Ampio Forms Luoxis Diagnostics To Commercialize ORP Technology - PR Newswire 02.11.13 | 04:02 am
- Ampio Pharmaceuticals Announces Participation At Upcoming Investor Conference - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals Announces Active IND For Optinaâ¿¢ For The Treatment Of Diabetic Macular Edema (DME) - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals, Inc. (AMPE) Announces Appointment Of Josh Disbrow As Chief Operating Officer Effective December 15, 2012 - PR Newswire 11.28.12 | 04:11 am
- Ampio Provides Progress Report On Clinical Programs In Preparation For Annual Shareholders Meeting - PR Newswire 11.14.12 | 04:11 am
- Ampio Provides Update Of Manufacturing Plans For Zertane⢠- PR Newswire 09.12.12 | 04:09 am
Partner Headlines for AMPE
- Ampio Pharma Initiates Phase III, Investors Extend Momentum - Seeking Alpha 05.03.13 | 09:05 am
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- BioPharma Stock Movers For Wednesday, August 29 - Seeking Alpha 08.29.12 | 09:08 am
- Ultimate Market Recap: Barclays Chairman Bows Out, ATPG Looking Slick - Wall St. Cheat Sheet 07.02.12 | 10:07 am
- Morning Market Movers - Benzinga 07.02.12 | 09:07 am
- Arena Pharma FADES Below $10 and 4 High Demand Stocks ATTRACTING Eyes - Wall St. Cheat Sheet 07.02.12 | 02:07 am
- Weekly Market Wrap: Stocks RALLY, Gold SPARKLES, Apple's New Products REVEALED - Wall St. Cheat Sheet 06.17.12 | 12:06 pm
- Company News for June 12, 2012 - Corporate Summary - Zacks 06.12.12 | 10:06 am
- These 5 Small Cap Stocks Are Up Better Than 10% Today - Benzinga 06.11.12 | 01:06 pm
- 4 Contrarian Stock Climbers in Trading Action as Centene Falls Hard - Wall St. Cheat Sheet 06.11.12 | 01:06 pm
